Senator Hatch and Terry
Terry & Marilu Henner
Dr. Gray & Terry
Terry receives Vity Award
Buddy and Bella
Buddy and Bella
Buddy and Bella
Terry on Tour
Terry on Tour
Terry on Tour
Terry at Marlene's - Federal Way
Soho, FL - 12/2011
Science Corner
Prenatal DHA and Infant Morbidity
| In a randomized, double-blind, controlled study involving pregnant women and their infants (n=834), supplementation with DHA during pregnancy (400 mg/d from 18-22 weeks gestation through parturition) was found to reduce the occurrence of colds in offspring at 1 month and influenced illness symptom duration at 1 month (OR=0.76), 3 months, and 6 months. Shorter durations of cough, (26% less) phlegm (15% less), and wheezing (30% less) were found at 1 month in the infants of mothers who had supplemented with DHA, however, interestingly, there was a 22% increase in the duration of rash. At 3 months, infants whose mothers received DHA spent 14% less time sick, and at 6 months, these same infants experienced shorter durations of fever (20%), nasal secretion (13%), difficulty breathing (54%), rash (23%) and “other illnesses” (25%), though interestingly, they also experienced a 74% increase in the duration of vomiting. The authors conclude, “DHA supplementation during pregnancy decreased the occurrence of colds in children at 1 month and influenced illness symptom duration at 1, 3, and 6 months.” Click here to read the study abstract. Subscription required to view the full text article. | |